Tango Therapeutics (TNGX) Q4 Loss Narrows to $0.29/Share vs $0.33 Estimate; Shares Surge 23%
Tango Therapeutics posts narrower-than-expected Q4 loss of $0.29/share vs $0.33 estimate; shares jump 23% on the biotech's results.
Tango Therapeutics posts narrower-than-expected Q4 loss of $0.29/share vs $0.33 estimate; shares jump 23% on the biotech's results.
Warehouse giant Costco Wholesale Corporation (NASDAQ: COST) on Thursday reported higher sales and net income for the second quarter of...
Ranger Energy Services reported financial results for the fourth quarter and full fiscal year ended December 31, 2025, delivering stable...
Financial Performance and Liquidity Revenues for the fourth quarter of 2025 reached $30.3 million, an increase from $21.2 million in...
Olaplex reported financial results for the fourth quarter and full fiscal year ended December 31, 2025, showing modest revenue growth...
Revenue Performance Global Ship Lease delivered robust top-line growth, reporting operating revenues of $190.9 million for the fourth quarter of...
Kroger reported financial results for the fourth quarter and full fiscal year 2025, delivering an earnings beat despite softer sales...
Financial Performance and Liquidity Altimmune reported a net loss of $27.4 million, or $0.27 per share, for the fourth quarter...
BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ), a leading membership-only warehouse chain, reported higher adjusted profit for the fourth quarter....
Revenue Performance CPI Card Group delivered a strong finish to 2025, with fourth-quarter revenue increasing 22% year-over-year to $153.1 million....